What is Prestalia, and how does it work?
- when one medicine to lower your high blood pressure is
- as the first medicine to lower your high blood pressure
if your doctor decides you are likely to need more than one medicine
It is not known if Prestalia is safe and effective in
What are the side effects of Prestalia?
- When pregnancy is detected, discontinue Prestalia as soon as
- Drugs that act directly on the renin-angiotens in system can cause
injury and death to the developing fetus
Prestalia can cause serious side effects, including:
- Serious allergic reactions that can be life
threatening. Stop taking Prestalia and get emergency medical help right
away if you get any of these symptoms of a serious allergic reaction:
People who are black and take Prestalia have a greater
risk of having a serious allergic reaction than people who are not black and
- Worsening of chest pain (angina) or a heart attack
(myocardial infarction) can happen after you start taking or increase your
dose of Prestalia. Get emergency help if you get worse chest pain or chest pain
that does not go away.
- Low blood pressure (hypotension) is most likely to
happen if you also:
If you feel faint or dizzy, lie down and call your
doctor right away.
- Increased amount of potassium in the blood. Your
doctor will check your potassium blood level during your treatment with
- Kidney problems. Some people with certain
conditions may develop kidney problems and may need to stop treatment with
Prestalia. Call your doctor if you get swelling in your feet, ankles, or hands,
or unexplained weight gain.
The most common side effects of Prestalia include:
Tell your doctor if you have any side effect that bothers
you or that does not go away.
These are not all the possible side effects of Prestalia.
For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects.
You may report side effects to FDA at 1-800- FDA-1088.
What is the dosage for Prestalia?
- The recommended starting dose of Prestalia is 3.5/2.5 mg
- Adjust dosage according to blood pressure goals. In general, wait 7 to
14 days between titration steps.
- The maximum recommended dose is 14/10 mg once daily.
- Prestalia may be used as initial therapy if a patient is
likely to need multiple drugs to achieve blood pressure goals.
- Consider use in patients unable to achieve adequate antihypertensive
effect with amlodipine monotherapy because of dose-limiting peripheral edema
caused by amlodipine.
- Administered as monotherapy, perindopril erbumine is an effective
treatment for hypertension in oncedaily doses ranging from 4 mg to 16 mg
- Amlodipine is effective in once-daily doses of 5 mg and 10 mg.
- Adverse reactions related to perindopril are generally uncommon and
independent of dose, while those related to amlodipine are a mixture of
dose-dependent phenomena (primarily peripheral edema) and dose-independent
phenomena, the former much more common than the latter.
Dosage Adjustment In Renal Impairment
- Prestalia is not recommended in patients with creatinine clearances <30
- For patients with creatinine clearance between 30 and 80 mL/min (mild or
moderate renal impairment), do not exceed 7/5 mg.
Monitoring In Elderly Patients (Over 65 Years Of Age)
- Monitor blood pressure for up to two weeks following titrations at
dosages above 7/5 mg in patients over 65 years of age.
Salt and sodium are the same.
What drugs interact with Prestalia?
- The pharmacokinetics of perindopril and amlodipine are
not altered when the drugs are co-administered.
- No drug interaction studies have been conducted with
Prestalia, although studies have been conducted with perindopril and
- Patients taking concomitant mTOR inhibitor (e.g. temsirolimus) therapy
may be at increased risk for angioedema.
- Patients taking concomitant neprilysin inhibitors may be at increased
risk for angioedema.
- Patients on diuretics, especially those in whom diuretic
therapy was recently instituted, may occasionally experience an excessive
reduction of blood pressure after initiation of therapy with Prestalia.
close medical supervision with the first dose of Prestalia, for at least two hours
and until blood pressure has stabilized for another hour.
- Perindopril can
attenuate potassium loss caused by thiazide diuretics.
Potassium Supplements And Potassium-Sparing Diuretics
- Potassium-sparing diuretics (spironolactone, amiloride,
triamterene, and others) or potassium supplements, or other drugs capable of
increasing serum potassium (indomethacin, heparin, cyclosporine and others) can
increase the risk of hyperkalemia.
- If concomitant use of such agents is indicated,
the patient’s serum potassium should be monitored frequently.
- Increased serum lithium levels and symptoms of lithium
toxicity have been reported in patients receiving ACE inhibitors during therapy
- When co-administering Prestalia and lithium, frequent monitoring
of serum lithium levels is recommended.
- Use of a diuretic may further increase
the risk of lithium toxicity.
- Nitritoid reactions (symptoms include facial flushing,
nausea, vomiting, and hypotension) have been reported rarely in patients on
therapy with injectable gold (sodium aurothiomalate) and concomitant ACE
Non-Steroidal Anti-Inflammatory Agents (NSAIDS) Including
Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)
- In patients who are elderly, volume-depleted (including
those on diuretic therapy), or with compromised renal function,
co-administration of NSAIDS, including selective COX-2 inhibitors, with ACE
inhibitors, including perindopril, may result in deterioration of renal
function, including possible acute renal failure. These effects are usually
- Monitor renal function periodically in patients receiving
perindopril and NSAID therapy.
- The antihypertensive effects of ACE inhibitors, including
perindopril, may be attenuated by NSAIDS, including selective COX-2 inhibitors.
Dual Blockade Of The Renin-Angiotensin System (RAS)
- Dual blockade of the RAS with angiotensin receptor
blockers, ACE inhibitors, or aliskiren is associated with increased risks of
hypotension, hyperkalemia, and changes in renal function (including acute renal
failure) compared to monotherapy.
- In most patients no benefit has been
associated with using two RAS inhibitors concomitantly.
- In general, avoid
combined use of RAS inhibitors. Closely monitor blood pressure, renal function,
and electrolytes in patients on Prestalia and other agents that affect the RAS.
- Do not co-administer aliskiren with Prestalia in patients
with diabetes. Avoid use of aliskiren with Prestalia in patients with renal
impairment (GFR <60 mL/min).
- Co-administration of multiple doses of 10 mg of
amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to
simvastatin compared to simvastatin administered alone.
- Limit the dose of
simvastatin in patients on amlodipine to 20 mg daily.
- A prospective study in renal transplant patients showed
an average 40% increase in trough cyclosporin levels during concomitant
treatment with amlodipine. Frequent monitoring of trough blood levels of
cyclosporine is recommended.
- Co-administration of the moderate CYP3A inhibitor
diltiazem increases the exposure to amlodipine by 60%.
erythromycin, also a moderate CYP3A inhibitor, does not impact the exposure to
- Strong CYP3A inhibitors (e.g., itraconazole) may increase the plasma
concentrations of the CYP3A substrate amlodipine to a greater extent.
for symptoms of hypotension and edema when amlodipine is co-administered with
moderate or strong CYP3A inhibitors to determine the need for dose adjustment.
- No information is available on the quantitative effects
of CYP3A inducers on amlodipine.
- Blood pressure should be monitored when
amlodipine is co-administered with CYP3A inducers.
Latest High Blood Pressure News
- COVID Antiviral Pill Approval
- Are Diet Drinks Any Better?
- Diabetes Ups Alzheimer’s Risk
- Key Protein in TBI Patients
- Breastfeeding Helps Postpartum Depression
- More Health News »
Trending on MedicineNet
- Breast Cancer Warning Signs
- CMT Disease
- Main Cause of Graves’ Disease
- RSV in Adults
- Ehlers-Danlos Syndrome
Is Prestalia safe to use while pregnant or breastfeeding?
- Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.
- Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.
- Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death.
- When pregnancy is detected, discontinue Prestalia as soon as possible.
- These adverse outcomes are usually associated with use of these drugs in the second and third trimester of pregnancy.
- Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents.
- Appropriate management of maternal hypertension during pregnancy is important to optimize outcomes for both mother and fetus.
- It is not known whether perindopril or amlodipine is excreted in human milk, but radioactivity was detected in the milk of lactating rats following administration of 14C-perindopril.
- Because of the potential for adverse effects on the nursing infant, decide whether to discontinue nursing or discontinue Prestalia.